{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:26:01Z","timestamp":1794702361874,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dementia with Lewy bodies (DLB) is the second most common dementia type in patients older than 65\u00a0years. Its atrophy patterns remain unknown. Its similarities to Parkinson's disease and differences from Alzheimer's disease are subjects of current research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of our study was (i) to form a group of patients with DLB (and a control group) and create a 3D MRI data set (ii) to volumetrically analyze the entire brain in these groups, (iii) to evaluate visual and manual metric measurements of the innominate substance for real-time diagnosis, and (iv) to compare our groups and results with the latest literature. We identified 102 patients with diagnosed DLB in our psychiatric and neurophysiological archives. After exclusion, 63 patients with valid 3D data sets remained. We compared them with a control group of 25 patients of equal age and sex distribution. We evaluated the atrophy patterns in both (1) manually and (2) via Fast Surfers segmentation and volumetric calculations. Subgroup analyses were done of the CSF data and quality of 3D T1 data sets.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Concordant with the literature, we detected moderate, symmetric atrophy of the hippocampus, entorhinal cortex and amygdala, as well as asymmetric atrophy of the right parahippocampal gyrus in DLB. The caudate nucleus was unaffected in patients with DLB, while all the other measured territories were slightly too moderately atrophied. The area under the curve analysis of the left hippocampus volume ratio (&lt;\u20093646mm<jats:sup>3<\/jats:sup>) revealed optimal 76% sensitivity and 100% specificity (followed by the right hippocampus and left amygdala). The substantia innominata\u2019s visual score attained a 51% optimal sensitivity and 84% specificity, and the measured distance 51% optimal sensitivity and 68% specificity in differentiating DLB from our control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In contrast to other studies, we observed a caudate nucleus sparing atrophy of the whole brain in patients with DLB. As the caudate nucleus is known to be the last survivor in dopamine-uptake, this could be the result of an overstimulation or compensation mechanism deserving further investigation. Its relative hypertrophy compared to all other brain regions could enable an imaging based identification of patients with DLB via automated segmentation and combined volumetric analysis of the hippocampus and amygdala.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02642-0","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:03:51Z","timestamp":1648155831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRI"],"prefix":"10.1186","volume":"22","author":[{"given":"Eya","family":"Khadhraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian Johannes","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Heiner","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Tim\u00e4eus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"2642_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44:673\u201383.","journal-title":"Psychol Med"},{"key":"2642_CR2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. The Lancet. 2015;386:1683\u201397.","journal-title":"The Lancet"},{"key":"2642_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt248","volume":"6","author":"E Mak","year":"2014","unstructured":"Mak E, Su L, Williams GB, O\u2019Brien JT. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther. 2014;6:18.","journal-title":"Alzheimers Res Ther"},{"key":"2642_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"2642_CR5","first-page":"27","volume":"23","author":"H Hanyu","year":"2002","unstructured":"Hanyu H, Asano T, Sakurai H, Tanaka Y, Takasaki M, Abe K. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol. 2002;23:27\u201332.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2642_CR6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00415-005-0611-8","volume":"252","author":"H Hanyu","year":"2005","unstructured":"Hanyu H, Tanaka Y, Shimizu S, Sakurai H, Iwamoto T, Abe K. Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer?s disease. J Neurol. 2005;252:482\u20134.","journal-title":"J Neurol"},{"key":"2642_CR7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neurobiolaging.2006.02.009","volume":"28","author":"H Hanyu","year":"2007","unstructured":"Hanyu H, Shimizu S, Tanaka Y, Hirao K, Iwamoto T, Abe K. MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol Aging. 2007;28:548\u201354.","journal-title":"Neurobiol Aging"},{"key":"2642_CR8","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"2642_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"2642_CR10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000117270","volume":"36","author":"F Pasquier","year":"1996","unstructured":"Pasquier F, Leys D, Weerts JGE, Mounier-Vehier F, Barkhof F, Scheltens P. Inter-and Intraobserver Reproducibility of Cerebral Atrophy Assessment on MRI Scans with Hemispheric Infarcts. Eur Neurol. 1996;36:268\u201372.","journal-title":"Eur Neurol"},{"key":"2642_CR11","doi-asserted-by":"crossref","first-page":"117012","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M. FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. NeuroImage. 2020;219.","journal-title":"NeuroImage."},{"key":"2642_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12859-019-2609-8","volume":"20","author":"SS Mikhael","year":"2019","unstructured":"Mikhael SS, Pernet C. A controlled comparison of thickness, volume and surface areas from multiple cortical parcellation packages. BMC Bioinformatics. 2019;20:55.","journal-title":"BMC Bioinformatics"},{"key":"2642_CR13","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/s41598-020-57951-6","volume":"10","author":"SN Yaakub","year":"2020","unstructured":"Yaakub SN, Heckemann RA, Keller SS, McGinnity CJ, Weber B, Hammers A. On brain atlas choice and automatic segmentation methods: a comparison of MAPER & FreeSurfer using three atlas databases. Sci Rep. 2020;10:2837.","journal-title":"Sci Rep"},{"key":"2642_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2017.04.035","volume":"156","author":"O Potvin","year":"2017","unstructured":"Potvin O, Dieumegarde L, Duchesne S. Freesurfer cortical normative data for adults using Desikan-Killiany-Tourville and ex vivo protocols. Neuroimage. 2017;156:43\u201364.","journal-title":"Neuroimage"},{"key":"2642_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"2642_CR16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull. 1979;86:420\u20138.","journal-title":"Psychol Bull"},{"key":"2642_CR17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591\u2013611.","journal-title":"Biometrika"},{"key":"2642_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/01621459.1972.10481232","volume":"67","author":"SS Shapiro","year":"1972","unstructured":"Shapiro SS, Francia RS. An Approximate Analysis of Variance Test for Normality. J Am Stat Assoc. 1972;67:215\u20136.","journal-title":"J Am Stat Assoc"},{"key":"2642_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/sim.4780120209","volume":"12","author":"P Royston","year":"1993","unstructured":"Royston P. A pocket-calculator algorithm for the shapiro-francia test for non-normality: An application to medicine. Stat Med. 1993;12:181\u20134.","journal-title":"Stat Med"},{"key":"2642_CR20","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scand J Stat. 1979;6:65\u201370.","journal-title":"Scand J Stat"},{"key":"2642_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2018.00138","volume":"10","author":"S Lehmann","year":"2018","unstructured":"Lehmann S, Delaby C, Boursier G, Catteau C, Ginestet N, Tiers L, et al. Relevance of A\u03b242\/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale. Front Aging Neurosci. 2018;10:138.","journal-title":"Front Aging Neurosci"},{"key":"2642_CR22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-141986","volume":"45","author":"H Struyfs","year":"2015","unstructured":"Struyfs H, Van Broeck B, Timmers M, Fransen E, Sleegers K, Van Broeckhoven C, et al. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-\u03b2 Isoforms for Early and Differential Dementia Diagnosis. J Alzheimers Dis. 2015;45:813\u201322.","journal-title":"J Alzheimers Dis"},{"key":"2642_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, et al. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2017;88:113\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2642_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-160322","volume":"54","author":"I van Steenoven","year":"2016","unstructured":"van Steenoven I, Aarsland D, Weintraub D, Londos E, Blanc F, van der Flier WM, et al. Cerebrospinal Fluid Alzheimer\u2019s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort. J Alzheimers Dis. 2016;54:287\u201395.","journal-title":"J Alzheimers Dis"},{"key":"2642_CR25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, et al. Pattern ofbrain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging. 2015;36:452\u201361.","journal-title":"Neurobiol Aging."},{"key":"2642_CR26","doi-asserted-by":"crossref","unstructured":"Burton\u00a0EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O\u2019Brien JT. Quantitative neurodegenerative pathology\u00a0does not explain the degree of hippocampal atrophy on MRI in degenerative dementia: Neuropathology and\u00a0hippocampal atrophy in dementia. Int J Geriatr Psychiatry. 2012;27:1267\u201374.","DOI":"10.1002\/gps.3774"},{"key":"2642_CR27","doi-asserted-by":"crossref","unstructured":"Burton EJ, Mukaetova-Ladinska\u00a0EB, Perry RH, Jaros E, Barber R, O\u2019Brien JT. Neuropathological correlates of volumetric MRI in autopsy-confirmed\u00a0Lewy body dementia. Neurobiol Aging. 2012;33:1228\u201336.","DOI":"10.1016\/j.neurobiolaging.2010.12.015"},{"key":"2642_CR28","doi-asserted-by":"crossref","unstructured":"Stoyka LE, Arrant AE, Thrasher DR, Russell DL, Freire J, Mahoney CL, et al. Behavioral defects associated with amygdala and cortical dysfunction in mice withseeded \u03b1-synuclein inclusions. Neurobiol Dis. 2020;134:104708.","DOI":"10.1016\/j.nbd.2019.104708"},{"key":"2642_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.162.3.385","volume":"162","author":"H F\u00f6rstl","year":"1993","unstructured":"F\u00f6rstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer\u2019s disease. Clinical and pathological findings. Br J Psychiatry J Ment Sci. 1993;162:385\u201392.","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2642_CR30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2010.11.015","volume":"33","author":"SH Choi","year":"2012","unstructured":"Choi SH, Jung TM, Lee JE, Lee S-K, Sohn YH, Lee PH. Volumetric analysis of the substantia innominata in patients with Parkinson\u2019s disease according to cognitive status. Neurobiol Aging. 2012;33:1265\u201372.","journal-title":"Neurobiol Aging"},{"key":"2642_CR31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.14802\/jmd.11014","volume":"4","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Lee JE, Shin SJ, Sohn YH, Lee PH. Analysis of the Substantia Innominata Volume in Patients with Parkinson\u2019s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer\u2019s Disease. J Mov Disord. 2011;4:68\u201372.","journal-title":"J Mov Disord"},{"key":"2642_CR32","first-page":"775","volume":"9","author":"LJ de Schipper","year":"2019","unstructured":"de Schipper LJ, Hafkemeijer A, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ. Regional Structural Hippocampal Differences Between Dementia with Lewy Bodies and Parkinson\u2019s Disease. J Park Dis. 2019;9:775\u201383.","journal-title":"J Park Dis"},{"key":"2642_CR33","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/gps.4719","volume":"32","author":"GJ Elder","year":"2017","unstructured":"Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O\u2019Brien JT, et al. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies: Hippocampal atrophy in dementia with Lewy bodies. Int J Geriatr Psychiatry. 2017;32:1182\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2642_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jalz.2018.09.011","volume":"15","author":"K Oppedal","year":"2019","unstructured":"Oppedal K, Ferreira D, Cavallin L, Lemstra AW, ten Kate M, Padovani A, et al. A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium. Alzheimers Dement. 2019;15:400\u20139.","journal-title":"Alzheimers Dement"},{"key":"2642_CR35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","volume":"62","author":"DS Knopman","year":"2003","unstructured":"Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of Cognitively Normal Elderly. J Neuropathol Exp Neurol. 2003;62:1087\u201395.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2642_CR36","doi-asserted-by":"crossref","unstructured":"Thal DR. Neurodegeneration in Normal Brain Aging and Disease. Sci Aging Knowl Environ. 2004;2004:pe26\u2013pe26.","DOI":"10.1126\/sageke.2004.23.pe26"},{"key":"2642_CR37","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuroimage.2008.05.055","volume":"42","author":"L Zaborszky","year":"2008","unstructured":"Zaborszky L, Hoemke L, Mohlberg H, Schleicher A, Amunts K, Zilles K. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage. 2008;42:1127\u201341.","journal-title":"Neuroimage"},{"key":"2642_CR38","doi-asserted-by":"crossref","first-page":"102333","DOI":"10.1016\/j.nicl.2020.102333","volume":"27","author":"C Abdelnour","year":"2020","unstructured":"Abdelnour C, Ferreira D, Oppedal K, Cavallin L, Bousiges O, Wahlund LO, et al. The combined effect of amyloid-\u03b2 and tau biomarkers on brain atrophy in dementia with Lewy bodies. NeuroImage Clin. 2020;27.","journal-title":"NeuroImage Clin."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02642-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:06:26Z","timestamp":1648206386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02642-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02642-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was ethically approved by the institutional review board of the University Medical Center G\u00f6ttingen (No. 10\/12\/2019, \u201cEthics Committee of the University of G\u00f6ttingen\u201d, Von-Siebold-Str. 4, 37075 G\u00f6ttingen, Germany) and adhered to the 2013 Helsinki Declaration.Due to the retrospective, observational nature of the study, the ethics committee (\u201cEthics Committee of the University of G\u00f6ttingen\u201d) waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests JW is an advisory board member of Abbott, Biogen, Boehringer Ingelheim, Immunogenetics, Lilly, MSD Sharp & Dohme, and Roche Pharma. JW received honoraria for lectures from the AGNP, Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., CSF-Society, Helios Klinikum Wuppertal, Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and Vitos Kurhessen-Bad Emstal. JW holds the following patents: PCT\/EP 2011 001724 and PCT\/EP 2015 052945.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}